What Researchers Did
Researchers studied 54 brain injury patients and 11 healthy individuals to explore how hyperbaric oxygen therapy affected β2-microglobulin levels in their blood and urine.
What They Found
Before hyperbaric oxygen therapy (HBOT), brain injury patients had significantly higher levels of β2-microglobulin in their blood and urine compared to healthy controls. In patients with conscious disturbance, blood β2-microglobulin levels were higher than in those without, both before and after HBOT. Urine β2-microglobulin levels in the conscious disturbance group were negatively correlated with Glasgow Coma Scale scores (R=-0.351).
What This Means for Canadian Patients
This study suggests that measuring β2-microglobulin levels could potentially help doctors assess the severity of brain injuries and monitor patient progress. The patients received HBOT at 2.0 ATA for 60 minutes daily over two 10-day courses, and future research could explore its specific impact on these markers and patient outcomes in Canadian brain injury care.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study involved a relatively small number of participants, which may limit the generalizability of its findings.